Levine RA, DO. Miladinovic B, PhD. Nardell K, MD. Galas J, MD

Slides:



Advertisements
Similar presentations
Considerations for the Neonate Delivered at Home Susan J Dulkerian, MD Director of Nurseries, Mercy Medical Center Fetus and Newborn Subcommitee Chair.
Advertisements

Variability in the Delivery Room Management of Infants with Congenital Anomalies Heather M. French, MD Perelman School of Medicine at the University of.
Copyright restrictions may apply JAMA Pediatrics Journal Club Slides: Potential Impact of CCHD Screening Peterson C, Ailes E, Riehle-Colarusso T, et al.
Case Identification for the Missouri Perinatal Hepatitis B Prevention Program Libby Landrum, RN, MSN Viral Hepatitis Prevention Manager Bureau HIV, STD,
Peds PLACE Changes effected CAR Effects in the SubC Survival across sites Support Intervention Current and planned telemedicine sites Conclusions Potential.
Newborn Screening for Critical Congenital Heart Disease
CODING Charles T. Hankins, MD. Coding for Neonatal-Perinatal Medicine 1.A neonatologist is asked to attend a repeat c- section. The infant is born.
Maryland Patient Safety Center 3Rs: Risks, Referrals and Readmissions.
Michigan Birth Defects Registry Overview and Status.
Pulse oximetry screening for congenital heart disease. Does it work? Is it worth it?
Critical Congenital Heart Disease Screening Saving Lives One Infant at a Time Christina Rust, MSN, RN.
Newborn Screening for Critical Congenital Heart Defects by Pulse Oximetry Fall CME Course 2012 Robert Jansen, MD St. Vincent Women’s Hospital.
Us Case 5 Delivery Coordination with Vital Records Update, Hearing Screening & Quality Monitoring to Aid Early Pediatric Care Care Theme: Maternal & Newborn.
Elective Cesarean Delivery, Neonatal Intensive Care Unit Admission, and Neonatal Respiratory Distress 楊明智.
2014 Summit Co-Convener:Founder: Patient Safety Science & Technology Summit 2014.
Request for Social Hold in Pediatrics Policy Updates TX-383 Pam Sanders, MSN, RNC-NIC, CENP Vice President, Women & Children’s Services.
Screening for Critical Congenital Heart Disease in Newborns Using Pulse Oximetry – New Jersey’s Experience Lori Freed Garg, MD, MPH New Jersey Department.
Pulse Oximetry screening for Cardiac malformations in the neonate Majd Abu-Harb September 2014.
TM Centers for Disease Control and Prevention National Center on Birth Defects and Developmental Disabilities Centers for Disease Control and Prevention.
Bob Bowman, MS Director of Genomics & Newborn Screening Indiana State Department of Health.
NUR 213 Ventral Septal Defect
© The Children's Mercy Hospital, /14 Critical Congenital Heart Disease (CCHD) Meagan Dorton, MSN, MBA, RN-CPN Pulse Oximetry Screening for Detecting.
Neonatal Arrhythmia.
Lecture II Congenital Heart Diseases Dr. Aya M. Serry 2015/2016.
Pulse Oximetry Screening for Critical Congenital Heart Disease (CCHD): The Wisconsin Experience Region IV Genetics Meeting September 11, 2012 Sharon Fleischfresser.
Why? 1 in 100 newborns have congenital heart defects 25% of all CHD are critical (CCHD) requiring intervention in the.
Congenital Heart Disease in South Texas Nadine Aldahhan, D.O.; Cherie Johnson, M.D., FACOG, MMM; Priscilla Gutierrez, RDMS, RDCS, RVT Christus Spohn Family.
Implementation of a Flowsheet to Better Manage Bilirubin Levels in Newborns Dr. Alia Chauhan, MD, FAAP Assistant Professor of Pediatrics & Family Medicine.
Emergency Medicine Junior Teaching Programme Aberdeen Royal Infirmary Adult Syncope Evaluation in the Emergency Department Jamie Cooper Teaching 4 th March.
Newborns At Risk for Sepsis Algorithm
Stillbirth in twins, exploring the optimal gestational age for delivery: a retrospective cohort study S Wood, S Tang, S Ross, R Sauve.
UOG Journal Club: July 2016 Ability of a preterm surveillance clinic to triage risk of preterm birth: a prospective cohort study J Min, HA Watson, NL Hezelgrave,
The lack of association of ST-T wave abnormalities to significant heart disease in asymptomatic neonates Sudheer R Gorla, MD 1, Daphne T Hsu, MD 2 and.
Recognition of Congenital Heart Disease Prenatal and newborn M. Beth Goens, MD Pediatric Cardiology University of New Mexico.
Management infant born with mother Chickenpox
Background Methods Results Discussion Conclusion
Objectives Identify key physical differences between the preterm infant and full term infant Identify normal vital signs for a newborn What are key signs.
Neonatal Cardiac assessment
Ruchi Kapoor, MD, PhD DSR 2 Cost Consciousness Project
UOG Journal Club: July 2016 Ability of a preterm surveillance clinic to triage risk of preterm birth: a prospective cohort study J Min, HA Watson, NL Hezelgrave,
RESPIRATORY DISTRESS SYNDROME IN NEONATES
Mark Drexler, MD Wednesday 5/1/13
Transient Tachypnea of newborn Wet lung; RDSII (TTN)
Risk Stratification of Chest Pain: Best Practices
Home Health Remote Patient Monitoring For Heart Failure
Screening for Critical Congenital Heart Defects with pulse oximetry:
El Paso First Healthplan, 1145 Westmoreland Drive
Is Patent Ductus Arteriosus Ligation Responsible for Adverse Outcome in Very Low Birth Weight (VLBW) Infants?  MJ. Qureshi, MD1*, M. Bamehrez, MD1, F.
THE UNIVERSITY of TENNESSEE HEALTH SCIENCE CENTER
Lorraine Freed Garg, MD, MPH Consultant in Public Health
Table 1: Patient Demographics
Caffeine Use and Brief Resolved Unexplained Events (BRUE)
2014 Texas Pediatric Society Electronic Poster Contest
Congenital Heart Diseases
Healthy Newborn.
Correlation of developmental outcome with severity of bronchopulmonary dysplasia in extremely low gestational age neonates Karen Belen, Chengqiu Lu, Narges.
Children with an increased risk of SED
Neonatal abstinence syndrome management: A quality improvement initiative to educate caregivers, & providers in the outpatient setting Nguyen J, MD*. Chau.
THE UNIVERSITY of TENNESSEE HEALTH SCIENCE CENTER
Echocardiograms in syncope work-up
The Late Preterm Infant
The Early Hearing Detection & Intervention Program Overview
Factors that Influence Hospital Screening Programs
RISK R isk of Perinatal and Early Childhood Infection
OUT-PATIENT IN A BED (OIB) PROCESS.
SCREENING AND MANAGEMENT OF ASYMPTOMATIC NEWBORNS
Reduction in Infant Cardiac Deaths in US States Implementing Policies to Screen Newborns for Critical Congenital Heart Disease Matthew Oster, MD, MPH Washington,
Management of At Risk Newborns for Hypoglycemia (First 24 Hrs of life)
PowerPoint 16:9 Screen Ratio Template *
Presentation transcript:

Management of a heart murmur in an asymptomatic neonate using a standardized approach Levine RA, DO. Miladinovic B, PhD. Nardell K, MD. Galas J, MD. Balakrishnan M, MD. INTRODUCTION RESULTS Provider impression of murmur CCHD (N=13) n (%) Correct: 0 (0%) PPS (N=61) Correct: 10 (16%) PDA (N=53) Correct: 95 (62%) VSD (N=31) Correct: 10 (32%) PFO (N=293) Correct: 44 (15%) Congenital heart disease (CHD) is the most common birth defect in the USA. Newborns murmur evaluations are costly & extensive with low likelihood of diagnosing critical congenital heart disease (CCHD). AAP defines CCHD as cardiac lesions requiring surgical/catheter intervention within the 1st year of life. There is no consensus on appropriate evaluation of a murmur in asymptomatic newborns. Provider impression was documented in 264 of 303 infants w/murmur evaluation Many infants had more than 1 cardiac lesion reported by echo Reason for exclusion n Murmur absent ≥24 hours 399 Evaluation <24 hours 43 Genetic syndrome 11 Abnormal fetal echo 9 Echo ± EKG not done Murmur evaluation >5 days 1 Demographics Follow-up n=290 CCHD n=13 Female n (%)  136 (46.9)  10 (76.9) GA wks (range) 39 2/7 (35-41) 39 2/7 (36-40) BW kg (range) 3.48 (2.14-5.06) 3.56 (2.75-4.22) Maternal age years (range) 28 (15-43) 30 (20-38) Medicaid n (%)  209 (73.1) 10 (76.9) Prenatal care 281 (98.2) 12 (92.3) TGH deliveries: 5,666 (8/2012-8/2013) Asymptomatic newborns with murmur: 775 CCHD: 13 Required NICU admission*: 4 Required immediate intervention: 2 Required intervention in 1st year of life: 2 Newborn Nursery: 9 No CCHD, requires outpatient cardiology follow-up: 289 Normal echo: 1 Excluded: 472 OBJECTIVES Only 35% of murmurs were accurately diagnosed by newborn nursery providers. In asymptomatic newborns with murmurs: Describe the problem with working up all asymptomatic newborns with a heart murmur Develop a screening algorithm for these newborns prior to hospital discharge Preform a cost analysis using our current guidelines prior to implementation of an algorithm. ESTIMATED COST ANALYSIS Total infants w/murmur evaluation: 303 Total infants w/evaluation made outside of guideline recommendations: 43 Family history of risk factors Follow-up N= 290 (%) CCHD N=13 (%) OR (95%CI) p-value Cardiotoxic meds (n=251*) 7 (2.9) 2 (16.7) 6.62 (1.2- 36) 0.03 Drowning (n=253*)  0 (0) 1 (8.3) NA 0.04 The following risks were not significant with p-value >0.05: IDM, Twin to twin transfusion syndrome, genetic syndrome, CHD, arrhythmia, cardiomyopathy, SIDS, sudden cardiac death, seizures, drowning *n represents number of times risk factor documented in total N * 3 of 4 NICU admissions had a positive pulse oximetry screen METHODS Test Cost per test Total cost (n=303) Potential cost savings (n=43) Pulse ox screen probe1 $7 $2,121 $301 EKG2 $450 $136,350 $19,350 Echo & doppler2 $3,909 $1,184,427 $172,000 Approximate total cost $1,322,898 $191,651 3 Prospective observational study Tampa General Hospital (TGH) ~5,500 births per year Study period: 8/2012 to 8/2013 Develop electronic medical record (EMR) template for cardiac history, clinical symptoms, & physical exam Current TGH/USF Newborn Nursery guidelines for any newborn murmur: cardiac history, physical exam, blood pressure (4 extremity), pulse oximetry screening, EKG, Echo, ± Pediatric cardiology consult PROPOSED ALGORITHM Inclusion criteria Exclusion criteria GA ≥ 35 0/7 wks BW ≥ 2 kg 1 to 5 days of life Asymptomatic Admitted to TGH’s newborn nursery Murmur diagnosis by Pediatrician or Nurse practitioner Fetal echo w/CHD Genetic/metabolic syndrome No EKG AND echo General exam findings Follow-up N= 290 (%) CCHD N=13 (%) OR (95%CI) p-value HR (>140 bpm)  102 (35.2)  9 (69.2) 4.15 (1.3- 13.8) 0.02 RR (>60) 8 (2.8) 2 (15.4) 6.4 (1.2- 33.8) 0.03 The following cardiac exam findings were not significant with a p-value >0.05: feeding difficulty, color, blood pressure (upper extremity vs. lower extremity) 1 Pulse ox costs from CDC statistics 2 Echo/EKG costs from TGH statistics CONCLUSIONS There is difficulty in distinguishing benign newborn murmurs from those of CCHD and determining appropriate follow-up in the newborn nursery An algorithm for asymptomatic newborns with a murmur can be developed Preliminary cost analysis using this algorithm shows significant cost savings. EMR template implementation resulted in >85% compliance and completion of documentation for cardiac history, clinical symptoms, & physical exam. Future direction: Implement the developed algorithm at TGH and evaluate utility & cost-effectiveness. Cardiac exam findings Follow-up N= 290 (%) CCHD N=13 (%) OR (95%CI) p-value Grade (≥3/6 ) (n=293*)  15 (5.4) 3 (23.1) 5.3 (1.32- 13.8) 0.03 The following newborn general findings were not significant with a p-value >0.05: S1/S2, timing, radiation, quality *n represents number of times finding documented in total N Newborn nursery providers determined appropriate follow-up in 94% of infants, however they were incorrect for all diagnosed w/CCHD. CONTACT: Dr. Rebecca Levine. Email: rlevine1@health.usf.edu. University of South Florida, Department of Pediatrics, Division of Neonatology, 1 Tampa General Circle, Room F170, Tampa, FL 33611.